Internal Medicine, Medical Oncology · Sugar Land, TX
NPI
1932373289
Since 2008
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
16659 Southwest Fwy, Suite 131
Sugar Land, TX, 77479
Phone (713) 441-9948
Groups this clinician bills Medicare through
Medicare paid, 2024
$93K
1,284 services
Medicare patients, 2024
273
Average age 75
Drug cost, 2024
$4.2M
1,950 prescriptions
Company payments, 2025
$191
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sindhu Nair was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 551 times for 238 patients. In total Sindhu Nair billed 1,284 services in 12 codes, and Medicare paid $93K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-06-07.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 551 | 238 | $12.36 | $6,809 |
| 99215 Office E&M - Established | Office | 550 | 225 | $125.06 | $69K |
| 99214 Office E&M - Established | Office | 101 | 86 | $86.03 | $8,689 |
| 99205 Office E&M - New | Office | 29 | 29 | $160.03 | $4,641 |
| 99223 Hospital E&M - Initial | Facility | 13 | 13 | $131.89 | $1,715 |
By year: 2022 $111K for 974 services; 2023 $87K for 752 services; 2024 $93K for 1,284 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sindhu Nair prescribed most often to Medicare patients was Anastrozole, with 373 prescriptions and refills. In total Sindhu Nair wrote 1,950 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 373 | 979 | 109 | $7,315 |
| Letrozole Generic | 158 | 393 | 49 | $3,394 |
| Eliquis Apixaban | 152 | 208 | 31 | $117K |
| Tamoxifen Citrate Generic | 126 | 319 | 38 | $2,568 |
| Gabapentin Generic | 76 | 116 | 19 | $1,509 |
| Dexamethasone Generic | 75 | 87 | 27 | $1,401 |
| Ondansetron Hcl Generic | 56 | 68 | 35 | $1,187 |
| Alendronate Sodium Generic | 54 | 122 | 18 | $450 |
| Valacyclovir Valacyclovir Hcl | 48 | 87 | 14 | $2,885 |
| Prochlorperazine Maleate Generic | 45 | 45 | 22 | $865 |
| Hydroxyurea Generic | 44 | 79 | Under 11 | $880 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 38 | 38 | 29 | $474 |
| Ibrance Palbociclib | 35 | 35 | Under 11 | $583K |
| Imbruvica Ibrutinib | 34 | 34 | Under 11 | $548K |
| Veozah Fezolinetant | 31 | 37 | Under 11 | $20K |
Brand drugs: - claims; generic drugs: 1,495 claims; opioid claims: 23.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sindhu Nair $191 ($191 in general payments such as food, travel and fees) from 7 companies. The largest payer was Gilead Sciences, Inc. with $83.56.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.